[ad_1] The third pharmacovigilance report on Levothyrox, released on Friday, July 6, 2018 by the French Medicines Agency (ANSM), still does not explain the wave of adverse effects seen by 1.43% of …
Read More »Levothyrox: The Medicines Agency Still Can not Explain Adverse Reactions
